Detalhe da pesquisa
1.
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Int J Cancer
; 152(8): 1659-1667, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250317
2.
Pediatric Tumors and Developmental Anomalies: A French Nationwide Cohort Study.
J Pediatr
; 259: 113451, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169337
3.
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort.
J Allergy Clin Immunol
; 149(5): 1744-1754.e8, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718043
4.
Glioblastoma Metabolism: Insights and Therapeutic Strategies.
Int J Mol Sci
; 24(11)2023 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37298093
5.
Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma.
Br J Clin Pharmacol
; 88(5): 2096-2117, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709655
6.
Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
Pediatr Blood Cancer
; 69(8): e29575, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373885
7.
SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
J Pathol
; 255(1): 1-15, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33999421
8.
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Lancet Oncol
; 22(9): 1312-1321, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416158
9.
Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.
Chembiochem
; 22(7): 1151-1160, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140906
10.
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(3): 446-455, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078813
11.
Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment.
Br J Haematol
; 191(5): 825-834, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700439
12.
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
Pediatr Blood Cancer
; 67(1): e28022, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571386
13.
An integrated genomic and metabolomic approach for defining survival time in adult oligodendrogliomas patients.
Metabolomics
; 15(5): 69, 2019 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31037432
14.
Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
J Neurooncol
; 145(1): 177-184, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522324
15.
Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
BMC Cancer
; 17(1): 419, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619014
16.
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 17(8): 1070-1080, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27324280
17.
Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Gastroenterology
; 149(4): 1017-29.e3, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26116798
18.
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).
BMC Cancer
; 15: 854, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541413
19.
Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).
J Med Genet
; 51(6): 355-65, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24737826
20.
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
Eur J Cancer
; 201: 113923, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377775